US-based Crown Bioscience acquires Nottingham oncology spin-out.
Crown Bioscience has acquired University of Nottingham spin-out Preclinical Oncology Services (PRECOS) for an unspecified sum.
The deal will add PRECOS’ expertise in oncology pre-clinical research and development services to Crown. As a result, the California-based firm will become one of the world’s largest suppliers of oncology services with bases in the US, the EU, and Asia.
Jean-Pierre Wery, president of Crown Bioscience said: “The acquisition represents the next step in expanding the range of specialized services we offer pharmaceutical…
